dpp4 vs sglt2 vs glp-1 dpp-4 inhibitors vs. agonist Insights into the Roles of GLP-1, DPP-4, and at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology Working mechanisms of GLP-1, GLP-1 – Comparison of GLP-1 receptor agonists

For some patients, symptoms will start to resolve after taking a few steps

The summary-level data of Genome-Wide Association Studies (GWASs) used in Mendelian randomization study can be accessed by the FinnGen ( and GTEx ( Abbreviations GLP-1 RAs: Glucagon-like peptide-1 receptor agonists DR: Diabetic retinopathy MR: Mendelian randomization HR: Hazard ratio SMR: Summary-data-based Mendelian randomization OR: Odds ratio CI: Confidence interval CVOTs: Cardiovascular outcome trials ICD-10: International Classification of Diseases, Revision 10 ATC: Anatomical Therapeutic Chemical DDD: Defined daily dose cis-eQTL: Cis-expression quantitative trait loci GWAS: Genome-Wide Association Study CVD: Cardiovascular disease SD: Standard deviation SNP: Single nucleotide polymorphism MAF: Minor allele frequency HEIDI: Heterogeneity in dependent instruments References Shah AR, Gardner TW

It's like giving your body a "please keep this muscle, were using it!" memo

Semaglutide Figure 3 shows the mean plasma concentration-time profile for semaglutide at steady-state (1.0 mg)

05/08 2018;doi:10.1530/endoabs.56.P918 Rudnicka E, Suchta K, Grymowicz M, et al